NR 565 / NR565 Advanced Pharmacology Midterm
Exam Practice Actual 2025/2026 with Detailed
Rationales | 100% Verified | Pass Guaranteed – A+
Graded
SECTION 1: Pharmacokinetics & Pharmacodynamics (12 questions)
Q1: A 68-year-old patient with cirrhosis is prescribed lorazepam for anxiety. The
nurse practitioner recognizes that this drug requires dosage reduction primarily
because of which pharmacokinetic change?
A. Decreased absorption due to reduced gastric blood flow
B. Decreased metabolism due to reduced hepatic first-pass effect
C. Increased distribution due to higher plasma protein binding
D. Increased elimination due to enhanced renal clearance
Correct Answer: B
Rationale: Cirrhosis reduces hepatic blood flow and CYP450 enzyme activity,
decreasing first-pass metabolism and increasing bioavailability of drugs like
lorazepam that undergo extensive hepatic metabolism, necessitating dosage
reduction.
Q2: A patient taking warfarin achieves a therapeutic INR of 2.5. The provider adds
amiodarone, and within 2 weeks the INR rises to 4.8. This drug interaction is best
explained by which pharmacokinetic mechanism?
,A. Amiodarone induces CYP2C9, increasing warfarin metabolism
B. Amiodarone inhibits CYP2C9, decreasing warfarin metabolism
C. Amiodarone displaces warfarin from albumin binding sites
D. Amiodarone increases renal excretion of warfarin
Correct Answer: B
Rationale: Amiodarone is a potent inhibitor of CYP2C9, the primary enzyme
responsible for metabolizing S-warfarin (the more potent isomer), leading to
decreased warfarin clearance and increased anticoagulant effect.
Q3: The nurse practitioner is teaching a patient about a new prescription for
propranolol. Which statement by the patient indicates understanding of the concept
of drug efficacy?
A. "This drug will block beta receptors in my heart."
B. "This drug will produce the maximum therapeutic effect possible."
C. "This drug requires a lower dose than metoprolol to work."
D. "This drug has fewer side effects than other beta blockers."
Correct Answer: B
Rationale: Efficacy refers to the maximum biological effect a drug can produce
regardless of dose; it describes the ceiling of therapeutic response, distinct from
potency (dose required) or selectivity (side effect profile).
Q4: A drug has a therapeutic index of 2.5. Which clinical implication is most
important for the nurse practitioner?
,A. The drug is very safe with a wide margin between effective and toxic doses
B. The drug requires therapeutic drug monitoring to avoid toxicity
C. The drug has high efficacy and low potency
D. The drug can be safely administered without dose adjustment
Correct Answer: B
Rationale: A low therapeutic index (narrow margin between ED50 and LD50)
indicates a narrow safety margin, requiring careful therapeutic drug monitoring and
individualized dosing to prevent toxicity.
Q5: A 55-year-old patient with renal impairment is prescribed gabapentin for
neuropathic pain. The nurse practitioner should adjust the dosing schedule based on
which pharmacokinetic parameter?
A. Increased volume of distribution due to decreased muscle mass
B. Decreased renal clearance requiring reduced dose or extended interval
C. Increased hepatic metabolism due to enzyme induction
D. Decreased protein binding leading to increased free drug concentration
Correct Answer: B
Rationale: Gabapentin is eliminated entirely by renal excretion unchanged; reduced
glomerular filtration rate in renal impairment decreases drug clearance, requiring
dose reduction or extended dosing intervals to prevent accumulation and toxicity.
Q6: A patient asks why the initial dose of digoxin is higher than subsequent
maintenance doses. The nurse practitioner explains that this is based on which
pharmacokinetic principle?
, A. Loading doses are used to achieve steady-state concentration rapidly
B. Loading doses increase the therapeutic index of the drug
C. Loading doses prevent first-pass metabolism
D. Loading doses increase the volume of distribution
Correct Answer: A
Rationale: A loading dose rapidly achieves the target steady-state plasma
concentration that would otherwise require approximately 4-5 half-lives to reach with
maintenance dosing alone; it does not alter pharmacokinetic parameters.
Q7: Which factor most significantly increases the volume of distribution of lipophilic
drugs in elderly patients?
A. Decreased total body water and increased body fat
B. Increased cardiac output and enhanced perfusion
C. Decreased plasma protein binding and hypoalbuminemia
D. Increased hepatic blood flow and enzyme activity
Correct Answer: A
Rationale: Aging increases adipose tissue and decreases total body water; lipophilic
drugs distribute extensively into fat compartments, increasing their volume of
distribution and potentially prolonging their half-life.
Q8: A patient taking phenytoin has subtherapeutic drug levels despite appropriate
dosing. The nurse practitioner suspects the patient is taking antacids concurrently.
This interaction occurs through which mechanism?
Exam Practice Actual 2025/2026 with Detailed
Rationales | 100% Verified | Pass Guaranteed – A+
Graded
SECTION 1: Pharmacokinetics & Pharmacodynamics (12 questions)
Q1: A 68-year-old patient with cirrhosis is prescribed lorazepam for anxiety. The
nurse practitioner recognizes that this drug requires dosage reduction primarily
because of which pharmacokinetic change?
A. Decreased absorption due to reduced gastric blood flow
B. Decreased metabolism due to reduced hepatic first-pass effect
C. Increased distribution due to higher plasma protein binding
D. Increased elimination due to enhanced renal clearance
Correct Answer: B
Rationale: Cirrhosis reduces hepatic blood flow and CYP450 enzyme activity,
decreasing first-pass metabolism and increasing bioavailability of drugs like
lorazepam that undergo extensive hepatic metabolism, necessitating dosage
reduction.
Q2: A patient taking warfarin achieves a therapeutic INR of 2.5. The provider adds
amiodarone, and within 2 weeks the INR rises to 4.8. This drug interaction is best
explained by which pharmacokinetic mechanism?
,A. Amiodarone induces CYP2C9, increasing warfarin metabolism
B. Amiodarone inhibits CYP2C9, decreasing warfarin metabolism
C. Amiodarone displaces warfarin from albumin binding sites
D. Amiodarone increases renal excretion of warfarin
Correct Answer: B
Rationale: Amiodarone is a potent inhibitor of CYP2C9, the primary enzyme
responsible for metabolizing S-warfarin (the more potent isomer), leading to
decreased warfarin clearance and increased anticoagulant effect.
Q3: The nurse practitioner is teaching a patient about a new prescription for
propranolol. Which statement by the patient indicates understanding of the concept
of drug efficacy?
A. "This drug will block beta receptors in my heart."
B. "This drug will produce the maximum therapeutic effect possible."
C. "This drug requires a lower dose than metoprolol to work."
D. "This drug has fewer side effects than other beta blockers."
Correct Answer: B
Rationale: Efficacy refers to the maximum biological effect a drug can produce
regardless of dose; it describes the ceiling of therapeutic response, distinct from
potency (dose required) or selectivity (side effect profile).
Q4: A drug has a therapeutic index of 2.5. Which clinical implication is most
important for the nurse practitioner?
,A. The drug is very safe with a wide margin between effective and toxic doses
B. The drug requires therapeutic drug monitoring to avoid toxicity
C. The drug has high efficacy and low potency
D. The drug can be safely administered without dose adjustment
Correct Answer: B
Rationale: A low therapeutic index (narrow margin between ED50 and LD50)
indicates a narrow safety margin, requiring careful therapeutic drug monitoring and
individualized dosing to prevent toxicity.
Q5: A 55-year-old patient with renal impairment is prescribed gabapentin for
neuropathic pain. The nurse practitioner should adjust the dosing schedule based on
which pharmacokinetic parameter?
A. Increased volume of distribution due to decreased muscle mass
B. Decreased renal clearance requiring reduced dose or extended interval
C. Increased hepatic metabolism due to enzyme induction
D. Decreased protein binding leading to increased free drug concentration
Correct Answer: B
Rationale: Gabapentin is eliminated entirely by renal excretion unchanged; reduced
glomerular filtration rate in renal impairment decreases drug clearance, requiring
dose reduction or extended dosing intervals to prevent accumulation and toxicity.
Q6: A patient asks why the initial dose of digoxin is higher than subsequent
maintenance doses. The nurse practitioner explains that this is based on which
pharmacokinetic principle?
, A. Loading doses are used to achieve steady-state concentration rapidly
B. Loading doses increase the therapeutic index of the drug
C. Loading doses prevent first-pass metabolism
D. Loading doses increase the volume of distribution
Correct Answer: A
Rationale: A loading dose rapidly achieves the target steady-state plasma
concentration that would otherwise require approximately 4-5 half-lives to reach with
maintenance dosing alone; it does not alter pharmacokinetic parameters.
Q7: Which factor most significantly increases the volume of distribution of lipophilic
drugs in elderly patients?
A. Decreased total body water and increased body fat
B. Increased cardiac output and enhanced perfusion
C. Decreased plasma protein binding and hypoalbuminemia
D. Increased hepatic blood flow and enzyme activity
Correct Answer: A
Rationale: Aging increases adipose tissue and decreases total body water; lipophilic
drugs distribute extensively into fat compartments, increasing their volume of
distribution and potentially prolonging their half-life.
Q8: A patient taking phenytoin has subtherapeutic drug levels despite appropriate
dosing. The nurse practitioner suspects the patient is taking antacids concurrently.
This interaction occurs through which mechanism?
